| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.
|
Blood
|
2008
|
3.66
|
|
2
|
Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.
|
J Clin Oncol
|
2007
|
3.32
|
|
3
|
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003.
|
Int J Cancer
|
2007
|
2.16
|
|
4
|
Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.
|
J Clin Oncol
|
2011
|
2.11
|
|
5
|
Activation of telomerase by human cytomegalovirus.
|
J Natl Cancer Inst
|
2009
|
1.92
|
|
6
|
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.
|
Blood
|
2010
|
1.89
|
|
7
|
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).
|
Blood
|
2002
|
1.85
|
|
8
|
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma.
|
Blood
|
2008
|
1.78
|
|
9
|
The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy.
|
Haematologica
|
2006
|
1.63
|
|
10
|
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
|
Blood
|
2008
|
1.62
|
|
11
|
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005.
|
Blood
|
2008
|
1.61
|
|
12
|
The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
|
Haematologica
|
2006
|
1.59
|
|
13
|
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
|
Leuk Lymphoma
|
2006
|
1.52
|
|
14
|
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.
|
Haematologica
|
2009
|
1.50
|
|
15
|
Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study.
|
J Clin Oncol
|
2012
|
1.46
|
|
16
|
Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib.
|
Leuk Lymphoma
|
2014
|
1.43
|
|
17
|
CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells.
|
Clin Cancer Res
|
2008
|
1.42
|
|
18
|
Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia?
|
Leuk Lymphoma
|
2009
|
1.41
|
|
19
|
Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden.
|
Int J Cancer
|
2012
|
1.39
|
|
20
|
Cancer risk among patients with myotonic muscular dystrophy.
|
JAMA
|
2011
|
1.38
|
|
21
|
Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association.
|
Gastroenterology
|
2008
|
1.36
|
|
22
|
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
|
Semin Oncol
|
2003
|
1.33
|
|
23
|
The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells.
|
Gastroenterology
|
2009
|
1.29
|
|
24
|
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.
|
Blood
|
2013
|
1.27
|
|
25
|
FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1.
|
J Pathol
|
2009
|
1.27
|
|
26
|
Autoimmunity and the risk of myeloproliferative neoplasms.
|
Haematologica
|
2010
|
1.25
|
|
27
|
Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.
|
J Natl Cancer Inst
|
2010
|
1.24
|
|
28
|
Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden.
|
Haematologica
|
2009
|
1.21
|
|
29
|
The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
|
Exp Cell Res
|
2002
|
1.21
|
|
30
|
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.
|
Haematologica
|
2009
|
1.19
|
|
31
|
Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene.
|
Cancer Res
|
2003
|
1.18
|
|
32
|
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial.
|
Blood
|
2003
|
1.17
|
|
33
|
Highly increased familial risks for specific lymphoma subtypes.
|
Br J Haematol
|
2009
|
1.16
|
|
34
|
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.
|
Int J Cancer
|
2009
|
1.12
|
|
35
|
Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.
|
Oncoimmunology
|
2012
|
1.10
|
|
36
|
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study.
|
Blood
|
2010
|
1.09
|
|
37
|
The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
|
Cancer Res
|
2007
|
1.06
|
|
38
|
Transcriptional regulation of 15-lipoxygenase expression by promoter methylation.
|
Exp Cell Res
|
2004
|
1.05
|
|
39
|
Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005.
|
Am J Hematol
|
2012
|
1.05
|
|
40
|
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
|
Haematologica
|
2004
|
1.04
|
|
41
|
Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.
|
Haematologica
|
2009
|
1.03
|
|
42
|
Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
|
Clin Cancer Res
|
2005
|
1.01
|
|
43
|
Mitogen-activated protein kinase cascade-mediated histone H3 phosphorylation is critical for telomerase reverse transcriptase expression/telomerase activation induced by proliferation.
|
Mol Cell Biol
|
2006
|
1.01
|
|
44
|
Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study.
|
Br J Haematol
|
2013
|
1.00
|
|
45
|
High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy.
|
Eur J Haematol
|
2012
|
1.00
|
|
46
|
Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes.
|
J Clin Oncol
|
2011
|
1.00
|
|
47
|
Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase.
|
FASEB J
|
2009
|
1.00
|
|
48
|
Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas.
|
Genes Chromosomes Cancer
|
2002
|
1.00
|
|
49
|
Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells.
|
Proc Natl Acad Sci U S A
|
2008
|
1.00
|
|
50
|
High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma.
|
Blood
|
2004
|
1.00
|
|
51
|
Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to in vivo haemolysis.
|
Ann Hematol
|
2004
|
0.98
|
|
52
|
Sorafenib has potent antitumor activity against multiple myeloma in vitro, ex vivo, and in vivo in the 5T33MM mouse model.
|
Cancer Res
|
2012
|
0.96
|
|
53
|
Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes.
|
Haematologica
|
2004
|
0.96
|
|
54
|
Telomere dysfunction induced by chemotherapeutic agents and radiation in normal human cells.
|
Int J Biochem Cell Biol
|
2012
|
0.96
|
|
55
|
TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.
|
Oncotarget
|
2014
|
0.94
|
|
56
|
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.
|
Haematologica
|
2011
|
0.94
|
|
57
|
A population-based assessment of mortality and morbidity patterns among patients with thymoma.
|
Int J Cancer
|
2010
|
0.93
|
|
58
|
Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
|
Hematol J
|
2003
|
0.93
|
|
59
|
No familial aggregation in chronic myeloid leukemia.
|
Blood
|
2013
|
0.92
|
|
60
|
Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009.
|
Blood
|
2011
|
0.92
|
|
61
|
Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome.
|
Am J Hum Genet
|
2003
|
0.92
|
|
62
|
Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma.
|
Int J Cancer
|
2006
|
0.92
|
|
63
|
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.
|
Haematologica
|
2012
|
0.91
|
|
64
|
Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.
|
Clin Lymphoma Myeloma
|
2009
|
0.91
|
|
65
|
Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis.
|
Haematologica
|
2003
|
0.90
|
|
66
|
Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity.
|
Cancer
|
2013
|
0.90
|
|
67
|
A method to visualize and adjust for selection bias in prevalent cohort studies.
|
Am J Epidemiol
|
2011
|
0.90
|
|
68
|
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study.
|
Br J Haematol
|
2003
|
0.89
|
|
69
|
Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.
|
PLoS One
|
2008
|
0.89
|
|
70
|
Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer.
|
Mol Cancer
|
2010
|
0.89
|
|
71
|
Timing of births and endometrial cancer risk in Swedish women.
|
Cancer Causes Control
|
2009
|
0.89
|
|
72
|
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase--a report from the Swedish CML Group.
|
Br J Haematol
|
2002
|
0.89
|
|
73
|
A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas.
|
Hematol J
|
2004
|
0.89
|
|
74
|
High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes.
|
BMC Immunol
|
2009
|
0.88
|
|
75
|
Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in sweden.
|
J Clin Oncol
|
2009
|
0.88
|
|
76
|
Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication.
|
Support Care Cancer
|
2007
|
0.88
|
|
77
|
Medicine. Tackling two diseases with HDL.
|
Science
|
2010
|
0.87
|
|
78
|
Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA.
|
Biochem Biophys Res Commun
|
2006
|
0.87
|
|
79
|
Patients' perceptions of having a central venous catheter or a totally implantable subcutaneous port system-results from a randomised study in acute leukaemia.
|
Support Care Cancer
|
2008
|
0.86
|
|
80
|
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study.
|
Blood
|
2011
|
0.86
|
|
81
|
Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues.
|
Cancer Lett
|
2007
|
0.86
|
|
82
|
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
|
Hematol J
|
2004
|
0.86
|
|
83
|
The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
|
Mol Cancer Res
|
2007
|
0.86
|
|
84
|
Survival patterns among lymphoma patients with a family history of lymphoma.
|
J Clin Oncol
|
2008
|
0.86
|
|
85
|
Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix.
|
Oncogene
|
2004
|
0.86
|
|
86
|
Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models.
|
BMC Med Res Methodol
|
2012
|
0.86
|
|
87
|
Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases.
|
Vaccine
|
2005
|
0.86
|
|
88
|
Thrombosis is associated with inferior survival in multiple myeloma.
|
Haematologica
|
2012
|
0.86
|
|
89
|
Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia-a randomized study.
|
Support Care Cancer
|
2003
|
0.85
|
|
90
|
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia.
|
Br J Haematol
|
2002
|
0.85
|
|
91
|
Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern.
|
Leuk Lymphoma
|
2007
|
0.85
|
|
92
|
15-Lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells.
|
Am J Physiol Lung Cell Mol Physiol
|
2009
|
0.84
|
|
93
|
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
|
Scand J Infect Dis
|
2004
|
0.84
|
|
94
|
Transcriptional regulation of 15-lipoxygenase expression by histone h3 lysine 4 methylation/demethylation.
|
PLoS One
|
2012
|
0.84
|
|
95
|
Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance.
|
Haematologica
|
2009
|
0.83
|
|
96
|
Premature senescence of T cells in long-term survivors of renal transplantation.
|
Biochem Biophys Res Commun
|
2011
|
0.83
|
|
97
|
[Pine processionary moth--a big health problem in southern Gotland. Results of a questionnaire study].
|
Lakartidningen
|
2009
|
0.83
|
|
98
|
Prior history of non-melanoma skin cancer is associated with increased mortality in patients with chronic lymphocytic leukemia.
|
Haematologica
|
2009
|
0.82
|
|
99
|
Epigenetic and transcriptional control of the 15-lipoxygenase-1 gene in a Hodgkin lymphoma cell line.
|
Exp Cell Res
|
2011
|
0.82
|
|
100
|
Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study.
|
Eur J Haematol
|
2012
|
0.82
|
|
101
|
Autoimmunity and risk for Hodgkin's lymphoma by subtype.
|
Haematologica
|
2009
|
0.82
|
|
102
|
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
|
Eur J Haematol
|
2006
|
0.81
|
|
103
|
Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: results of a prospective long-term follow-up.
|
Hematology
|
2012
|
0.81
|
|
104
|
EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells.
|
Virus Genes
|
2005
|
0.81
|
|
105
|
Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia.
|
Clin Lymphoma Myeloma
|
2009
|
0.81
|
|
106
|
Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.
|
Eur J Haematol
|
2006
|
0.81
|
|
107
|
Leukotriene B4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells.
|
Blood
|
2004
|
0.80
|
|
108
|
Optimizing investigator-led oncology research in Europe.
|
Haematologica
|
2012
|
0.80
|
|
109
|
Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.
|
Semin Hematol
|
2011
|
0.80
|
|
110
|
Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemia.
|
Clin Lymphoma Myeloma Leuk
|
2013
|
0.79
|
|
111
|
Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study.
|
Br J Haematol
|
2009
|
0.79
|
|
112
|
Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune disease.
|
J Clin Oncol
|
2010
|
0.79
|
|
113
|
Hodgkin lymphoma risk following infectious and chronic inflammatory diseases: a large population-based case-control study from Sweden.
|
Int J Hematol
|
2015
|
0.78
|
|
114
|
Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients.
|
Ann Hematol
|
2009
|
0.78
|
|
115
|
The expression of cytosolic phospholipase A2 and biosynthesis of leukotriene B4 in acute myeloid leukemia cells.
|
Eur J Haematol
|
2007
|
0.78
|
|
116
|
Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms.
|
Genome Med
|
2009
|
0.78
|
|
117
|
Connective tissue growth factor is expressed in malignant cells of Hodgkin lymphoma but not in other mature B-cell lymphomas.
|
Am J Clin Pathol
|
2010
|
0.78
|
|
118
|
Stimulation of T-cell cytokine production and NK-cell function by IL-2, IFN-alpha and histamine treatment during remission of non-Hodgkin's lymphoma.
|
Hematol J
|
2003
|
0.78
|
|
119
|
A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia.
|
Leuk Res
|
2003
|
0.78
|
|
120
|
Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells.
|
J Pathol
|
2011
|
0.78
|
|
121
|
Real-time polymerase chain reaction determination of cytokine mRNA expression profiles in Hodgkin's lymphoma.
|
Haematologica
|
2004
|
0.78
|
|
122
|
Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies.
|
Scand J Infect Dis
|
2004
|
0.78
|
|
123
|
Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: novel insight into the inflammatory features of classical Hodgkin lymphoma.
|
FEBS J
|
2008
|
0.78
|
|
124
|
Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia.
|
Haematologica
|
2006
|
0.78
|
|
125
|
Expression patterns of CD33 and CD15 predict outcome in patients with acute myeloid leukemia.
|
Leuk Lymphoma
|
2008
|
0.77
|
|
126
|
Familial longevity: the older you are, the older your father may have been.
|
J Am Geriatr Soc
|
2005
|
0.77
|
|
127
|
Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection.
|
Scand J Infect Dis
|
2012
|
0.77
|
|
128
|
Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.
|
PLoS One
|
2013
|
0.77
|
|
129
|
Infection in infancy and subsequent risk of developing lymphoma in children and young adults.
|
Blood
|
2010
|
0.77
|
|
130
|
Self-reported fertility in long-term survivors of acute myeloid leukemia.
|
Ann Hematol
|
2014
|
0.77
|
|
131
|
TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders.
|
Int J Med Sci
|
2008
|
0.76
|
|
132
|
Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas.
|
Clin Lymphoma Myeloma
|
2008
|
0.76
|
|
133
|
Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study.
|
Ann Intern Med
|
2016
|
0.76
|
|
134
|
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
|
Clin Drug Investig
|
2014
|
0.76
|
|
135
|
Development of Hodgkin lymphoma in homozygotic triplets with constitutional deletion in MKL1.
|
Blood
|
2013
|
0.76
|
|
136
|
Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma.
|
Int J Cancer
|
2008
|
0.76
|
|
137
|
Interleukin-13 stimulation of the mediastinal B-cell lymphoma cell line Karpas-1106P induces a phenotype resembling the Hodgkin lymphoma cell line L1236.
|
Exp Hematol
|
2009
|
0.75
|
|
138
|
Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy.
|
Cancer Med
|
2014
|
0.75
|
|
139
|
Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.
|
Acta Haematol
|
2012
|
0.75
|
|
140
|
Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia - very long follow-up.
|
Br J Haematol
|
2014
|
0.75
|
|
141
|
Expression of the signal transduction molecule zeta in peripheral and tumour-associated lymphocytes in Hodgkin's disease in relation to the Epstein-Barr virus status of the tumour cells.
|
Br J Haematol
|
2002
|
0.75
|
|
142
|
Molecular cytogenetic approach to the diagnosis of splenic lymphoma: a case report of blastoid mantle cell lymphoma.
|
Leuk Lymphoma
|
2003
|
0.75
|
|
143
|
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma.
|
Acta Oncol
|
2004
|
0.75
|
|
144
|
The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival.
|
Epidemiology
|
2014
|
0.75
|
|
145
|
Sick leave due to depressive disease: not a risk factor for the development of malignant lymphoma.
|
Eur J Epidemiol
|
2005
|
0.75
|
|
146
|
Parental longevity and survival in elderly patients with Hodgkin's lymphoma.
|
Haematologica
|
2002
|
0.75
|
|
147
|
Chronic myeloid leukemia presenting late in pregnancy. Report of a case and a questionnaire reflecting diversity in management options.
|
Ann Hematol
|
2008
|
0.75
|
|
148
|
Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006).
|
J Clin Oncol
|
2013
|
0.75
|
|
149
|
Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60-75 years of age with multiple myeloma stages II and III.
|
Hematol J
|
2003
|
0.75
|